Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  TLR8 agonist VTX-2337
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Biomarker Response to Cetuximab and VTX-2337 in Treating Patients with Stage II-IVA Head and Neck Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-002, NCI-2014-01430, UPCI #14-002, VRXP-A106, NCT02124850
Start Over